Krelor 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.
MFDS item code 201604101 · Approved 2016.06.30
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct in patients with primary hypercholesterolemia or mixed dyslipidemia that are not controlled by diet and exercise. It lowers LDL cholesterol and total cholesterol levels, delaying the progression of atherosclerosis, and is also used with diet or other treatments in patients with homozygous familial hypercholesterolemia. Additionally, it helps improve cholesterol levels in pediatric patients aged 10 to 17 years with a family history or risk factors. It can also serve as an adjunct to diet in patients with primary dysbetalipoproteinemia. In middle-aged patients with elevated high-sensitivity C-reactive protein levels and cardiovascular disease risk factors, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures. Overall, it is used to improve cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on the administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, patients with allergies to this drug's components, those with severe liver impairment, patients with muscle disorders, and those with significantly reduced kidney function should not take this drug. Women who are pregnant or nursing, or those of childbearing age who are not using appropriate contraceptive methods should avoid this drug. Additionally, patients vulnerable to muscle-related disorders should avoid high doses. This drug contains lactose, so patients with certain genetic conditions like lactose intolerance should not take it. Patients with a history of liver disease or excessive alcohol consumption should have regular liver function tests while taking this medication. Those with conditions such as hypothyroidism or nephrotic syndrome should have these conditions treated first. If symptoms of myalgia or muscle weakness occur, patients should immediately inform their doctor, and if necessary, blood tests should be conducted to check for muscle damage. Caution is advised when taking other medications as some may increase the risk of muscle problems. High doses may cause temporary changes in kidney function, thus kidney function tests should also be considered. Asian patients may have higher systemic exposure to this drug, requiring potential dosage adjustments. This drug may rarely cause serious skin reactions or liver damage; if symptoms such as rash or jaundice occur, the medication should be discontinued immediately, and medical consultation should be sought. During pregnancy or nursing, this drug can be harmful to the fetus or infant; thus, its use should be avoided, and women who could become pregnant should ensure they are utilizing appropriate contraceptive methods. There is no specific antidote for overdose; treatment is symptomatic, and liver function and muscle-related tests should be continuously monitored. Lastly, this drug is unlikely to affect driving or operating machinery but caution should be taken as dizziness may occur.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug eruption resembling psoriasis, lupus-like syndrome, muscle tear, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.
Pink round film-coated tablet
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.